Glucagon-like peptide 1 (GLP1) receptor agonists and risk for ischemic optic neuropathy: A meta-analysis of randomised controlled trials
Diabetes Obes Metab
.
2025 Feb;27(2):1005-1009.
doi: 10.1111/dom.16076.
Epub 2024 Nov 20.
Authors
Giovanni Antonio Silverii
1
,
Laura Pala
2
,
Barbara Cresci
2
,
Edoardo Mannucci
1
Affiliations
1
Experimental and Clinical Biomedical Sciences 'Mario Serio' Department, University of Florence, Florence, Italy.
2
Diabetology Unit, AOU Careggi, Florence, Italy.
PMID:
39563616
PMCID:
PMC11701179
DOI:
10.1111/dom.16076
No abstract available
Keywords:
GLP‐1 analogue; antidiabetic drug; antiobesity drug; clinical trial.
Publication types
Letter